COSMO — Farmacosmo SpA Income Statement
0.000.00%
Last trade - 00:00- €16.11m
- €22.31m
- €63.00m
Annual income statement for Farmacosmo SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 44.1 | 58 | 65.7 | 71.2 | 63 |
| Cost of Revenue | |||||
| Gross Profit | 2.91 | 3.51 | 2.31 | 4.01 | 4.16 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 43.2 | 57 | 67.3 | 74.4 | 65.3 |
| Operating Profit | 0.866 | 1.07 | -1.65 | -3.24 | -2.28 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.522 | 0.659 | -2.16 | -4.18 | -3.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.373 | 0.413 | -2 | -3.93 | -3.07 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.373 | 0.413 | -2 | -3.23 | -2.97 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.373 | 0.413 | -2 | -3.23 | -2.97 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.011 | 0.012 | -0.053 | -0.05 | -0.051 |
| Dividends per Share |